Detalhe da pesquisa
1.
Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma.
Nat Commun;
15(1): 3014, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38589406
2.
CD4+ T cell immunity against cutaneous melanoma encompasses multifaceted MHC II-dependent responses.
Sci Immunol;
9(91): eadi9517, 2024 Jan 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38241401
3.
Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome.
Front Immunol;
13: 979993, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36003398
4.
The tumour immune landscape and its implications in cutaneous melanoma.
Pigment Cell Melanoma Res;
34(3): 529-549, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32939993
5.
Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model.
PLoS One;
15(4): e0226444, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32240177
6.
Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence.
Nat Cancer;
1(2): 197-209, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33305293
7.
Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients.
Oncoimmunology;
8(2): e1537581, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30713793
8.
Publisher Correction: Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence.
Nat Cancer;
1(4): 470, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35121971